Emerging perspectives on the mechanism of action of gabapentin

Neurology

Volumn 44, Issue 6, 1994, Pages S10-S16

  Taylor, Charles P ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; AMINO ACID; ANTICONVULSIVE AGENT; GABAPENTIN; LEUCINE; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR;

ANIMAL; BRAIN; CHEMISTRY; DRUG EFFECT; HUMAN; ION CHANNEL; METABOLISM; REVIEW;

ACETIC ACIDS; AMINO ACIDS; ANIMAL; ANTICONVULSANTS; BRAIN; HUMAN; ION CHANNELS; LEUCINE; NEUROTRANSMITTERS; RECEPTORS, NEUROTRANSMITTER;

EID: 0002223825     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Jasper HH, Ward AA Jr, Pope A. Basic mechanisms of the epilepsies. Boston: Little Brown & Co., 1969.
2. Delgado-Escueta AV, Ward AA Jr, Woodbury DM, et al. Basic mechanisms of the epilepsies. Adv Neurol 1986;44:1-1096.
3. Levy RH, Dreifuss FE, Mattson RH, et al. Antiepileptic drugs, 3rd ed. NY: Raven Press, 1989:1-1025.
4. Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 1990;42: 223-286.
5. Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia 1993;34(suppl 5):S1-S8.
6. Taylor CP. Mechanism of action of new antiepileptic drugs. In: Chadwick D, ed. New trends in epilepsy management: the role of gabapentin. London: Royal Society of Medicine Services, 1993:13-40.
7. Suman-Chauhan N, Webdale L, Hill DR, et al. Characterisation of [3H]-gabapentin binding to a novel site in rat brain: ho- mogenate binding studies. Eur J Pharmacol Mol Pharmacol 1993;244:293-301.
8. Taylor CP, Vartanian MG, Yuen P-W, et al. Potent and stereo- specific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res 1993;14:11-15.
9. US Gabapentin Study Group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebocontrolled, parallel-group study. Neurology 1993;43:2292-2298.
10. Goa KL, Sorkin EM. Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy. Drugs 1993;46:409-427.
11. Bartoszyk GD, Fritschi E, Herrmann M, et al. Indications for an involvement of the GABA-system in the mechanism of action of gabapentin [abstract], Naunyn-Schmiedebergs Arch Pharmacol 1983;322(suppl):R94.
12. Satzinger G. Antiepileptics from gamma-aminobutyric acid. Arzneim-Forsch (Drug Res) 1994;44:261-266.
13. Stewart BH, Kugler AR, Thompson PR, et al. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of lack of proportionality between increasing dose and drug levels in plasma. Pharm Res 1993;10:276-281.
14. Bartoszyk GD, Meyerson N, Reimann W, et al. Gabapentin. In: Meldrum BS, Porter RJ, eds. New anticonvulsant drugs. London: John Libbey, 1986:147-163.
15. Kondo T, Fromm GH, Schmidt B. Comparison of gabapentin with other antiepileptic and GABAergic drugs. Epilepsy Res 1991;8:226-231.
16. Reimann W. Inhibition by GABA, baclofen, and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action? Eur J Pharmacol 1983;94: 341-344.
17. Schlicker E, Reimann W, Göthert M. Gabapentin decreases monoamine release without affecting acetylcholine release in the brain. Arzneimittelforschung 1985;35:1347-1349.
18. Rock DM, Kelly KM, Macdonald RL. Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Res 1993;16:89-98.
19. Löscher W, Hönack D, Taylor CP. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci Lett 1991;128:150-154.
20. Götz E, Feuerstein TJ, Lais A, et al. Effects of gabapentin on release of y-aminobutyric acid from slices of rat neostriatum. Arzneimittelforschung 1993;43:636-638.
21. Kocsis JD, Honmou O. Gabapentin increases GABA-induced depolarization in rat neonatal optic nerve. Neurosci Lett 1994; 169:181-184.
22. Taylor CP, Vartanian MG, Andruszkiewicz R, et al. 3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents. Epilepsy Res 1992;11:103-110.
23. Goldlust and Oxender, unpublished observations.
24. Welty DF, personal communication.
25. Vollmer K-O, von Hodenberg A, Kölle EU. Pharmacokinetics and metabolism of gabapentin in rat, dog, and man. Arzneimittelforschung 1986;36:830-839.
26. Palfreyman MG, Schechter PJ, Buckett WR, et al. The pharmacology of GABA-transaminase inhibitors. Biochem Pharmacol 1981;30:817-824.
27. Haas HL, Wieser HG. Gabapentin: action on hippocampal slices of the rat and effects in human epileptics. Northern European Epilepsy Meeting, York, England, 1986.
28. Wamil AW, McLean MJ, Taylor CP. Multiple cellular actions of gabapentin [abstract]. Neurology 1991;41(suppl 1):140.
29. Bartoszyk GD. Gabapentin and convulsions provoked by excitatory amino acids [abstract]. Naunyn-Schmiedebergs Arch Pharmacol 1983;324(suppl):R24.
30. Oles RJ, Singh L, Hughes J, et al. The anticonvulsant action of gabapentin involves the glycine/NMD A receptor [abstract], Soc Neurosci Abstr 1990;16:783.
31. Hill DR, Suman-Chauhan N, Woodruff GN. Localization of [3H]-gabapentin to a novel site in rat brain: autoradiographic studies. Eur J Pharmacol Mol Pharmacol 1993;244:303-309.
32. Kelly KM, Rock DM, Macdonald RL. Gabapentin does not affect V-methyl-D-aspartate receptor currents or voltage-dependent calcium currents in cultured rodent neurons [abstract]. Ann Neurol 1991;30:292.
33. Taylor CP, Rock DM, Weinkauf RJ, et al. In vitro and in vivo electrophysiology effects of the anticonvulsant gabapentin [abstract]. Soc Neurosci Abstr 1988;14:866.
34. Taylor CP. The anticonvulsant lamotrigine blocks sodium currents from cloned alpha-subunits of rat brain Na+ channels in a voltage-dependent manner but gabapentin does not [abstract], Soc Neurosci Abstr 1993;19:1631.
35. Wamil AW, McLean MJ. Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture. Epilepsy Res 1994;17:1-11.
36. Ragsdale DS, Scheuer T, Catterall WA. Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs. Mol Pharmacol 1991;40:756-765.
37. Su T-Z, personal communication.
38. Shotwell MA, Jayme DW, Kilberg MS, et al. Neutral amino acid transport systems in Chinese hamster ovary cells. J Biol Chem 1981;256:5422-5427.
39. Welty DF, Schielke GP, Vartanian MG, et al. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate. Epilepsy Res 1993;16:175-181.
40. Thurlow RJ, Brown JP, Gee NS, et al. [3H]-gabapentin may label a system-L-like neutral amino acid carrier in brain. Eur J Pharmacol Mol Pharmacol 1993;247:341-345.
41. Lunney E, personal communication.